Neuro biotech Nido closes after phase 2 study fails to move needle in rare disease
Neuro biotech Nido closes after phase 2 study fails to move needle in rare disease
Body unavailable. Use the original source.
Neuro biotech Nido closes after phase 2 study fails to move needle in rare disease
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.